Circulating Biomarkers World Congress 2015

SelectBio_WorldCongress2015_700x233


In March, the second annual SELECTBIO Circulating Biomarkers World Congress 2015 brought together academic researchers and industry participants to present research, industry and commercial activities in the translation of circulating biomarkers.

Speakers presented unpublished data on extracellular vesicles and extracellular nucleic acids as circulating biomarkers, fitting into three overarching themes:

• Circulating DNA, RNA and tumor cells
• Exosomes and microvesicles
• Sample preparation and analysis

Most presentations focused on the importance of circulating cells, specifically tumor cells as the key to understanding the biology of diseases such as cancer, as they provide potential to guide treatment decisions, assess burden and monitor progression. (Need of upcoming improvements in isolation technology.) This conference solidified the importance of this emerging field of non-invasive liquid biopsies, whether it’s via blood, saliva or other body fluids. Specifically, it was great to hear researcher David Wong from the University of California Los Angeles discuss saliva-based exosomes for liquid biopsies as a noninvasive biofluid, and Xandra Breakefield, a geneticist from Massachusetts General Hospital, provide an overview on extracellular RNA in biofluids as biomarkers of disease.

QIAGEN’s own scientist, Alexander Wolf, presented during the technology spotlight portion of the event. His presentation focused on the purification of circulating cell-free DNA from plasma using specific technological advancements. The technology can process high sample volumes, extracting quantitative DNA with a low elution volume and a throughput of 96 samples per run. Therefore, blood samples can be processed in 1-2 hours.

Overall, we had a wonderful time at the SELECTBIO Circulating Biomarkers World Congress 2015, and look forward to next year’s gathering.

For more information on the SELECTBIO Circulating Biomarkers World Congress 2015 visit: http://selectbiosciences.com/conferences/index.aspx?conf=CBWC2015

Abhishek Sharma, Msc., MBA

Senior Global Market Manager, Discovery Sciences

Abhishek Sharma trained as a biochemist and has hands-on experience in nucleic acid and protein purification, tissue culturing and recombinant DNA technology. Previously, he was as a market analyst on emerging technologies in life science research. Sharma also worked in a USA-based healthcare consultancy on the discovery, development and commercialization of new disease treatments across multiple therapeutic areas. Currently, he’s involved with managing QIAGEN’s sample preparation portfolio, specializing in RNA technologies.

Your email address will not be published. Required fields are marked *